Changes of clinical signs of visceral leishmaniasis in adults;Clinica della leishmaniosi viscerale dell'adulto: Cambiano le modalità di presentazione?

Parassitologia

Volumn 46, Issue 1-2, 2004, Pages 225-226

  Gaeta, G B ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; AMPHOTERICIN B; LIPOSOME; PROTOZOON ANTIBODY;

ADULT; CHRONIC LIVER DISEASE; CONFERENCE PAPER; COST OF ILLNESS; DEVELOPED COUNTRY; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ORGAN TRANSPLANTATION; PREGNANCY; VISCERAL LEISHMANIASIS; AIDS RELATED COMPLEX; ANIMAL; BLOOD; FEMALE; IMMUNOLOGY; ISOLATION AND PURIFICATION; LEISHMANIA; MALE; PARASITOLOGY; PATHOLOGY; POSTOPERATIVE COMPLICATION; PREGNANCY COMPLICATION; REVIEW;

HUMAN IMMUNODEFICIENCY VIRUS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; ANIMALS; ANTIBODIES, PROTOZOAN; FEMALE; HUMANS; LEISHMANIA; LEISHMANIASIS, VISCERAL; LIPOSOMES; MALE; POSTOPERATIVE COMPLICATIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 4844223739     PISSN: 00482951     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. Berman JD (1997). Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 24: 684-703.
2. Berman J, Dietze R (1999). Treatment of visceral leishmaniasis with amphotericin B colloidal dispersion. Chemotherapy 45 (suppl 1): 54-66.
3. Boelaert M, Croft SL, Desjeux P, et al. (2002). Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2002; 2: 494-501.
4. Davidson RN, Di Martino L, Gradoni L et al. Short course treatment of visceral leishmaniasis with liposomal amphotericin B (Ambisome). Clin Infect Dis 1996; 22:938-943.
5. Roberts LJ, Handman F, Foote SJ. Leishmaniasis. BMJ 2000; 321:801-804.
6. Sundar S, Jha TK, Thakur CP et al. Oral miltefosine for indian visceral leishmaniasis. N Engl J Med 2002; 347:1739-46.
7. Sundar S, Reed SG, Sharma S, et al. Circulating T helper 1 (TH1) cell- and TH2 cell-associated cytokines in Indian patients with visceral leishmaniasis. Am J Trop Med Hyg 1997; 56:522-25.
8. WHO. Report on the consultative meeting on Leishmania / HIVco-infection, Rome, 6-7 September, 1994. Geneva: WHO; WHO/LEISH/95.35/1995.